CLINICAL_TRIALS
trial_result
· 2020-03-20
Clinical Trial Update: Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients [Phase 1, Phase 2]
Summary
Phase 1/2 trial update on immunotherapy for HLA-A2 positive stage II-IV melanoma; trial terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-03-20